Chemoradiotherapy of anal carcinoma: Survival and recurrence in an unselected national cohort

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 2, 2012, Pages

  Bentzen, Anne Gry ^a,b   Guren, Marianne G ^c   Wanderås, Eva H ^c   Frykholm, Gunilla ^d,h   Tveit, Kjell M ^c,e   Wilsgaard, Tom ^b   Dahl, Olav ^f   Balteskard, Lise ^a,g  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g NORTHERN NORWAY REGIONAL HEALTH AUTHORITY   (Norway)

^h NORWEGIAN RADIATION PROTECTION AUTHORITY   (Norway)

Author keywords

Anal cancer; Chemoradiotherapy; Patterns of failure; Treatment outcomes; Unselected national cohort

Indexed keywords

ADVERSE OUTCOMES; ANAL CANCER; COMORBIDITY; COMPLETE RESPONSE; CONTROL RATES; CURATIVE INTENT; LOCOREGIONAL RECURRENCE; MULTIVARIABLE ANALYSIS; OVERALL SURVIVAL; PATTERNS OF FAILURE; PRIMARY TREATMENT; RECURRENCE-FREE SURVIVAL; SALVAGE SURGERY; SQUAMOUS CELL CARCINOMA; TREATMENT GUIDELINES; TREATMENT OPTIMIZATION; TREATMENT OUTCOMES; TUMOR SITE; UNSELECTED NATIONAL COHORT;

CHEMOTHERAPY; DISEASES; SURGERY; TUMORS;

CHEMORADIOTHERAPY;

CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CHEMORADIOTHERAPY; COHORT ANALYSIS; COMORBIDITY; DISTANT METASTASIS; ELDERLY CARE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION ENTEROPATHY; RADIATION HAZARD; RECURRENCE FREE SURVIVAL; SALVAGE THERAPY; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; COHORT STUDIES; COLOSTOMY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; GROIN; GUIDELINE ADHERENCE; HUMANS; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; NORWAY; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SALVAGE THERAPY; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84861098231     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.12.062     Document Type: Article

References (17)

1. N.D. Nigro, V.K. Vaitkevicius, and B. Considine Jr Combined therapy for cancer of the anal canal: a preliminary report Dis Colon Rectum 17 1974 354 356
2. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research Lancet 348 1996 1049 1054
3. J.A. Ajani, K.A. Winter, and L.L. Gunderson Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial JAMA 299 2008 1914 1921 (Pubitemid 351574921)
4. D. Peiffert, M. Giovannini, and M. Ducreux High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study Ann Oncol 12 2001 397 404 (Pubitemid 32288698)
5. R. James, S. Wan, and R. Glynne-Jones A randomised trial of chemoradiation using mitomycin or cisplatin with or without maintenance cisplatin/5-Fu in squamous cell carcinoma of the anus. ACT II [abstract ] J Clin Oncol 2009 27 No 18S (June 20 Supplement): LBA4009
6. K.Y. Bilimoria, D.J. Bentrem, and C.E. Rock Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: Analysis of patients from the National Cancer Data Base Dis Colon Rectum 52 2009 624 631
7. E. Deniaud-Alexandre, E. Touboul, and E. Tiret Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal Int J Radiat Oncol Biol Phys 56 2003 1259 1273 (Pubitemid 36842877)
8. P.J. Nilsson, C. Svensson, and S. Goldman Epidermoid anal cancer: A review of a population-based series of 308 consecutive patients treated according to prospective protocols Int J Radiat Oncol Biol Phys 61 2005 92 102 (Pubitemid 40039110)
9. J. Northover, R. Glynne-Jones, and D. Sebag-Montefiore Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I) Br J Cancer 102 2010 1123 1128
10. R.J. Myerson, E.D. Outlaw, and A. Chang Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience Int J Radiat Oncol Biol Phys 75 2009 428 435
11. R.J. Myerson, M.C. Garofalo, and N.I. El Elective clinical target volumes for conformal therapy in anorectal cancer: A radiation therapy oncology group consensus panel contouring atlas Int J Radiat Oncol Biol Phys 74 2009 824 830
12. C. Crowley, A.Z. Winship, and M.A. Hawkins Size does matter: Can we reduce the radiotherapy field size for selected cases of anal canal cancer undergoing chemoradiation? Clin Oncol (R Coll Radiol) 21 2009 376 379
13. C. Ortholan, M. Resbeut, and J.M. Hannoun-Levi Anal canal cancer: Management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study) Int J Radiat Oncol Biol Phys 2011 Article in press. E-pub.
14. P. Das, S. Bhatia, and C. Eng Predictors and patterns of recurrence after definitive chemoradiation for anal cancer Int J Radiat Oncol Biol Phys 68 2007 794 800 (Pubitemid 46818735)
15. K. Saarilahti, P. Arponen, and L. Vaalavirta Chemoradiotherapy of anal cancer is feasible in elderly patients: treatment results of mitomycin-5-FU combined with radiotherapy at Helsinki University Central Hospital 1992-2003 Acta Oncol 45 2006 736 742 (Pubitemid 44385098)
16. J.A. Ajani, K.A. Winter, and L.L. Gunderson Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11) Cancer 116 2010 4007 4013
17. S.K. Mai, G. Welzel, and V. Haegele The influence of smoking and other risk factors on the outcome after radiochemotherapy for anal cancer Radiat Oncol 2 2007 30